T1rho Imaging of Liver in Presence of Iron

Status Completed

Clinical Trial Summary

Liver T1rho is elevated in response to accumulation of extracellular matrix proteins during fibrosis. The presence of hepatic iron overload; however, can shorten the T1rho value. With proper correction, we can remove this confounding factor and improve the reliability of T1rho for early diagnosis of liver fibrosis. Patients with early-stage liver fibrosis confirmed by biopsy will be recruited at the Prince of Wales Hospital (Hong Kong). Thirty patients and twenty healthy volunteers will be recruited. The liver iron content will be measured using the established T2* MRI relaxometry. Breathhold black blood T1rho relaxometry will be used to collect T1rho data. The measured T1rho will be retrospectively corrected to remove the shortening effect caused by iron. We will use ANOVA to compare the measurement with and without fibrosis. We will use Pearson correlations between the disease state and the imaging measurements, and ROC analysis to determine the diagnostic value of the proposed method.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05154643
Study type	Observational
Source	Chinese University of Hong Kong
Contact
Status	Completed
Phase
Start date	August 1, 2019
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06308757` - Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis	N/A
Recruiting	`NCT06051669` - Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US
Completed	`NCT06244550` - Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors	N/A
Recruiting	`NCT06098417` - Biomarkers in the Diagnosis and Prognosis of NAFLD
Not yet recruiting	`NCT03623360` - Functional MRI to Determine Severity of Cirrhosis
Recruiting	`NCT01965418` - A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial	Phase 4
Not yet recruiting	`NCT01133184` - Improved Prevention of Perinatal Hepatitis B Transmission	Phase 4
Completed	`NCT00043303` - Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis	Phase 2
Completed	`NCT03872024` - Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients	N/A
Recruiting	`NCT05912179` - Prospective Single Centre Observational Study to Compare the Diagnostic Yield of Different Modalities of Liver Biopsy
Recruiting	`NCT04533828` - 68Ga-FAPI PET/CT in Liver Fibrosis Patients	Early Phase 1
Completed	`NCT04573543` - The Role of Immune Semaphorins in NAFLD
Recruiting	`NCT03277651` - Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension	N/A
Completed	`NCT01707472` - Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis	Phase 2
Completed	`NCT01810458` - Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
Completed	`NCT01988753` - Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
Completed	`NCT01934777` - Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis	Phase 3
Completed	`NCT02060162` - Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
Completed	`NCT00049842` - Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)	Phase 3
Recruiting	`NCT06063785` - Multispectral Optoacoustic Tomography in Patients With Cystic Fibrosis